Germino J, Bastia D
Cell. 1981 Mar;23(3):681-7. doi: 10.1016/0092-8674(81)90431-1.
The replication terminus of the drug resistance factor R6K has been cloned into the plasmid vectors pBR313 and pBR322. When the exogenously added DNA is replicated in vitro using cell extracts prepared from Escherichia coli, the plasmid replication terminus temporarily arrests the progression of the unidirectionally moving replication fork at or near the cloned terminator sequence. When the relative location of the terminator sequence is changed with respect to the replication origin, the point of arrest of the replication fork shifts correspondingly to the new location of the terminator. Termination of replication takes place in vitro regardless of whether the cell extracts used in the in vitro reaction are prepared from E. coli with a resident terminus sequence containing plasmid. From these observations we conclude that the termination of replication in vitro is identical or very similar to that observed in vivo, membrane association is not necessary for the activity of the replication terminus and the terminus sequence does not code for a transacting factor necessary for termination of replication. Therefore, any transacting factor which may be needed for the termination of replication must be coded by the host chromosome.
耐药因子R6K的复制终止区已被克隆到质粒载体pBR313和pBR322中。当使用从大肠杆菌制备的细胞提取物在体外复制外源添加的DNA时,质粒复制终止区会在克隆的终止序列处或其附近暂时阻止单向移动的复制叉前进。当终止序列相对于复制起点的相对位置发生变化时,复制叉的停滞点会相应地转移到终止区的新位置。无论体外反应中使用的细胞提取物是从含有驻留终止序列质粒的大肠杆菌中制备的,复制终止都能在体外发生。从这些观察结果我们得出结论,体外复制终止与体内观察到的情况相同或非常相似,膜结合对于复制终止区的活性不是必需的,并且终止序列不编码复制终止所需的反式作用因子。因此,复制终止可能需要的任何反式作用因子都必须由宿主染色体编码。